Peptide YY3-36(Pfizer)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePeptide YY3-36(Pfizer)
Drug Alias NamePYYpeptide YY [3-36]PYY3-36
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNeuropeptide Y receptor type 2 agonists
TargetsNeuropeptide Y receptor type 2
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMarina BiotechMerck Sharp & Dohme CorpPfizer Inc
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A